News

Disparate reimbursement policies disincentivize clinicians from vaccinating adults with lower incomes.

Treatment with remdesivir was not associated with statistically significant clinical benefits. However, the numerical reduction in time to clinical improvement in those treated earlier requires confirmation in larger studies.

Michael K. Gusmano, PhD, discusses the importance of maintaining ethical standards in research evaluating potential therapeutics and vaccines for COVID-19.

A New York City nurse reflects on "peak-week" in a COVID unit.

The SIMPLE trial appears to have demonstrated that patients receiving the 5-day dose duration achieved similar improvement in clinical status compared to patients who received the 10-day dosing duration.

US and China research shows the coronavirus is not present in semen samples, unlike Ebola and the Zika virus.

Investigators aim to assess a vaccine derived from weakened adenovirus in 1100 patients over 2-6 months.

About 10% of older Britons were hospitalized for respiratory disease in a new sudy. But patients who lived alone faced triple the risk.

A daily round up of our COVID-19 coverage.

The CDC lists Brucellosis among the top 8 concerning zoonotic diseases in the United States.

Hollis O’Neal, MD, the national primary investigator for the Cytovale early sepsis detection system, discusses sepsis and COVID-19 and provides an overview of his pilot study.

Over half of residents with positive test results were asymptomatic at the time of testing, during a recent survey.

A trio of clinicians pen perspective on the federal and state efforts being made to reduce rapid and severe virus spread in at-risk facilities.

A pair of experts cite fair innings in their debate, wondering if age should play a role in deciding who qualifies for life-saving coronavirus treatments.

Tune in for a daily COVID-19 update.

Hypertension, obesity, and diabetes are the most observed comorbidities among infected patients in the New York City area.

More than 2 million ambulatory clinic encounters and 100,000 hospitalizations annually are due to the disease.

New expert recommendations follow from evidence showing the virus is a thrombo-inflammatory process that can affect multiple organs in addition to the lungs.

Older patients who live alone are at a higher risk of being hospitalized for respiratory disease, according to a new study.

A hospital case series of patients with both COVID-19 and HIV describes recovery, but highlights the need to refine treatment.

Previous research has suggested an association between bacteria from the Bovis group streptococci, Clostridium septicum and colorectal cancer

In part 2 of the interview, Ryan W. Stevens, PharmD, BCIDP, discusses the risks associated with convalescent plasma and highlights what clinicians should know.

In part 1 of our interview, Ryan W. Stevens, PharmD, BCIDP, provides an overview of how convalescent plasma has been used to treat infectious diseases including coronaviruses.

Two infants who presented to New York hospitals with fevers ended up testing positive for COVID-19 and serve as a reminder of the importance of infection-prevention protocols, according to a new paper.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of April 19, 2020.

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

Stay up to date on the latest coronavirus news from Friday, April 24th.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

As much of the American economy has been restricted, economic impacts are beginning to translate into food insecurity.

The FDA released a drug safety communication cautioning against the use of hydroxychloroquine or chloroquine for COVID-19 outside of hospital and clinical trial settings.